0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Breath Molecular Diagnostic Device Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-26H16887
Home | Market Reports | Health| Medical Devices & Equipment
Global Breath Molecular Diagnostic Device Market Research Report 2024
BUY CHAPTERS

Global Breath Molecular Diagnostic Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-26H16887
Report
November 2025
Pages:175
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Breath Molecular Diagnostic Device Market Size

The global Breath Molecular Diagnostic Device market is projected to grow from US$ 263 million in 2024 to US$ 575 million by 2031, at a CAGR of 12.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Breath Molecular Diagnostic Device Market

Breath Molecular Diagnostic Device Market

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Breath Molecular Diagnostic Device leading manufacturers including NIOX Group plc, Headway, Sunvou Medical Electronics Co, CAIRE (NGK), Richen Holding, Meridian Bioscience, CAPNIA, Inc., Kibion​​, Otsuka Electronics, LEYI BIOLOGY, etc., dominate supply; the top five capture approximately % of global revenue, with NIOX Group plc leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Breath Molecular Diagnostic Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Breath Molecular Diagnostic Device Market Report

Report Metric Details
Report Name Breath Molecular Diagnostic Device Market
Accounted market size in 2024 US$ 263 million
Forecasted market size in 2031 US$ 575 million
CAGR 12.0%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • C13 Type
  • NO Type
  • H2/CO Type
  • VOCs Type
Segment by Application
  • Hospital
  • Clinic
  • Physical Examination Center
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NIOX Group plc, Headway, Sunvou Medical Electronics Co, CAIRE (NGK), Richen Holding, Meridian Bioscience, CAPNIA, Inc., Kibion​​, Otsuka Electronics, LEYI BIOLOGY, Eco Physics AG, Shenzhen Breax, QUINTRON, Beijing Wanliandaxinke Instruments Co, SIMES SIKMA, Beijing Safe Heart Technology, e-LinkCare Meditech Co, ChromX Health, Huiyuen Tech, Owlstone Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Breath Molecular Diagnostic Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Breath Molecular Diagnostic Device Market growing?

Ans: The Breath Molecular Diagnostic Device Market witnessing a CAGR of 12.0% during the forecast period 2025-2031.

What is the Breath Molecular Diagnostic Device Market size in 2031?

Ans: The Breath Molecular Diagnostic Device Market size in 2031 will be US$ 575 million.

Who are the main players in the Breath Molecular Diagnostic Device Market report?

Ans: The main players in the Breath Molecular Diagnostic Device Market are NIOX Group plc, Headway, Sunvou Medical Electronics Co, CAIRE (NGK), Richen Holding, Meridian Bioscience, CAPNIA, Inc., Kibion​​, Otsuka Electronics, LEYI BIOLOGY, Eco Physics AG, Shenzhen Breax, QUINTRON, Beijing Wanliandaxinke Instruments Co, SIMES SIKMA, Beijing Safe Heart Technology, e-LinkCare Meditech Co, ChromX Health, Huiyuen Tech, Owlstone Medical

What are the Application segmentation covered in the Breath Molecular Diagnostic Device Market report?

Ans: The Applications covered in the Breath Molecular Diagnostic Device Market report are Hospital, Clinic, Physical Examination Center, Other

What are the Type segmentation covered in the Breath Molecular Diagnostic Device Market report?

Ans: The Types covered in the Breath Molecular Diagnostic Device Market report are C13 Type, NO Type, H2/CO Type, VOCs Type

1 Study Coverage
1.1 Introduction to Breath Molecular Diagnostic Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Breath Molecular Diagnostic Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 C13 Type
1.2.3 NO Type
1.2.4 H2/CO Type
1.2.5 VOCs Type
1.3 Market Segmentation by Application
1.3.1 Global Breath Molecular Diagnostic Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Physical Examination Center
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Breath Molecular Diagnostic Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Breath Molecular Diagnostic Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Breath Molecular Diagnostic Device Sales Estimates and Forecasts 2020-2031
2.4 Global Breath Molecular Diagnostic Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Breath Molecular Diagnostic Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Breath Molecular Diagnostic Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 C13 Type Market Size by Manufacturers
3.5.2 NO Type Market Size by Manufacturers
3.5.3 H2/CO Type Market Size by Manufacturers
3.5.4 VOCs Type Market Size by Manufacturers
3.6 Global Breath Molecular Diagnostic Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Breath Molecular Diagnostic Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Breath Molecular Diagnostic Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Breath Molecular Diagnostic Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Breath Molecular Diagnostic Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Breath Molecular Diagnostic Device Sales and Revenue by Type (2020-2031)
6.4 North America Breath Molecular Diagnostic Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Breath Molecular Diagnostic Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Breath Molecular Diagnostic Device Sales and Revenue by Type (2020-2031)
7.4 Europe Breath Molecular Diagnostic Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Breath Molecular Diagnostic Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Breath Molecular Diagnostic Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Breath Molecular Diagnostic Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Breath Molecular Diagnostic Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Breath Molecular Diagnostic Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Breath Molecular Diagnostic Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Breath Molecular Diagnostic Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Breath Molecular Diagnostic Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Breath Molecular Diagnostic Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Breath Molecular Diagnostic Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 NIOX Group plc
11.1.1 NIOX Group plc Corporation Information
11.1.2 NIOX Group plc Business Overview
11.1.3 NIOX Group plc Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.1.4 NIOX Group plc Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 NIOX Group plc Breath Molecular Diagnostic Device Sales by Product in 2024
11.1.6 NIOX Group plc Breath Molecular Diagnostic Device Sales by Application in 2024
11.1.7 NIOX Group plc Breath Molecular Diagnostic Device Sales by Geographic Area in 2024
11.1.8 NIOX Group plc Breath Molecular Diagnostic Device SWOT Analysis
11.1.9 NIOX Group plc Recent Developments
11.2 Headway
11.2.1 Headway Corporation Information
11.2.2 Headway Business Overview
11.2.3 Headway Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.2.4 Headway Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Headway Breath Molecular Diagnostic Device Sales by Product in 2024
11.2.6 Headway Breath Molecular Diagnostic Device Sales by Application in 2024
11.2.7 Headway Breath Molecular Diagnostic Device Sales by Geographic Area in 2024
11.2.8 Headway Breath Molecular Diagnostic Device SWOT Analysis
11.2.9 Headway Recent Developments
11.3 Sunvou Medical Electronics Co
11.3.1 Sunvou Medical Electronics Co Corporation Information
11.3.2 Sunvou Medical Electronics Co Business Overview
11.3.3 Sunvou Medical Electronics Co Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.3.4 Sunvou Medical Electronics Co Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Sunvou Medical Electronics Co Breath Molecular Diagnostic Device Sales by Product in 2024
11.3.6 Sunvou Medical Electronics Co Breath Molecular Diagnostic Device Sales by Application in 2024
11.3.7 Sunvou Medical Electronics Co Breath Molecular Diagnostic Device Sales by Geographic Area in 2024
11.3.8 Sunvou Medical Electronics Co Breath Molecular Diagnostic Device SWOT Analysis
11.3.9 Sunvou Medical Electronics Co Recent Developments
11.4 CAIRE (NGK)
11.4.1 CAIRE (NGK) Corporation Information
11.4.2 CAIRE (NGK) Business Overview
11.4.3 CAIRE (NGK) Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.4.4 CAIRE (NGK) Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 CAIRE (NGK) Breath Molecular Diagnostic Device Sales by Product in 2024
11.4.6 CAIRE (NGK) Breath Molecular Diagnostic Device Sales by Application in 2024
11.4.7 CAIRE (NGK) Breath Molecular Diagnostic Device Sales by Geographic Area in 2024
11.4.8 CAIRE (NGK) Breath Molecular Diagnostic Device SWOT Analysis
11.4.9 CAIRE (NGK) Recent Developments
11.5 Richen Holding
11.5.1 Richen Holding Corporation Information
11.5.2 Richen Holding Business Overview
11.5.3 Richen Holding Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.5.4 Richen Holding Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Richen Holding Breath Molecular Diagnostic Device Sales by Product in 2024
11.5.6 Richen Holding Breath Molecular Diagnostic Device Sales by Application in 2024
11.5.7 Richen Holding Breath Molecular Diagnostic Device Sales by Geographic Area in 2024
11.5.8 Richen Holding Breath Molecular Diagnostic Device SWOT Analysis
11.5.9 Richen Holding Recent Developments
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Corporation Information
11.6.2 Meridian Bioscience Business Overview
11.6.3 Meridian Bioscience Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.6.4 Meridian Bioscience Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Meridian Bioscience Recent Developments
11.7 CAPNIA, Inc.
11.7.1 CAPNIA, Inc. Corporation Information
11.7.2 CAPNIA, Inc. Business Overview
11.7.3 CAPNIA, Inc. Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.7.4 CAPNIA, Inc. Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 CAPNIA, Inc. Recent Developments
11.8 Kibion​​
11.8.1 Kibion​​ Corporation Information
11.8.2 Kibion​​ Business Overview
11.8.3 Kibion​​ Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.8.4 Kibion​​ Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Kibion​​ Recent Developments
11.9 Otsuka Electronics
11.9.1 Otsuka Electronics Corporation Information
11.9.2 Otsuka Electronics Business Overview
11.9.3 Otsuka Electronics Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.9.4 Otsuka Electronics Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Otsuka Electronics Recent Developments
11.10 LEYI BIOLOGY
11.10.1 LEYI BIOLOGY Corporation Information
11.10.2 LEYI BIOLOGY Business Overview
11.10.3 LEYI BIOLOGY Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.10.4 LEYI BIOLOGY Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 LEYI BIOLOGY Recent Developments
11.11 Eco Physics AG
11.11.1 Eco Physics AG Corporation Information
11.11.2 Eco Physics AG Business Overview
11.11.3 Eco Physics AG Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.11.4 Eco Physics AG Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Eco Physics AG Recent Developments
11.12 Shenzhen Breax
11.12.1 Shenzhen Breax Corporation Information
11.12.2 Shenzhen Breax Business Overview
11.12.3 Shenzhen Breax Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.12.4 Shenzhen Breax Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Shenzhen Breax Recent Developments
11.13 QUINTRON
11.13.1 QUINTRON Corporation Information
11.13.2 QUINTRON Business Overview
11.13.3 QUINTRON Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.13.4 QUINTRON Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 QUINTRON Recent Developments
11.14 Beijing Wanliandaxinke Instruments Co
11.14.1 Beijing Wanliandaxinke Instruments Co Corporation Information
11.14.2 Beijing Wanliandaxinke Instruments Co Business Overview
11.14.3 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.14.4 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Beijing Wanliandaxinke Instruments Co Recent Developments
11.15 SIMES SIKMA
11.15.1 SIMES SIKMA Corporation Information
11.15.2 SIMES SIKMA Business Overview
11.15.3 SIMES SIKMA Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.15.4 SIMES SIKMA Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 SIMES SIKMA Recent Developments
11.16 Beijing Safe Heart Technology
11.16.1 Beijing Safe Heart Technology Corporation Information
11.16.2 Beijing Safe Heart Technology Business Overview
11.16.3 Beijing Safe Heart Technology Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.16.4 Beijing Safe Heart Technology Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Beijing Safe Heart Technology Recent Developments
11.17 e-LinkCare Meditech Co
11.17.1 e-LinkCare Meditech Co Corporation Information
11.17.2 e-LinkCare Meditech Co Business Overview
11.17.3 e-LinkCare Meditech Co Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.17.4 e-LinkCare Meditech Co Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 e-LinkCare Meditech Co Recent Developments
11.18 ChromX Health
11.18.1 ChromX Health Corporation Information
11.18.2 ChromX Health Business Overview
11.18.3 ChromX Health Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.18.4 ChromX Health Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 ChromX Health Recent Developments
11.19 Huiyuen Tech
11.19.1 Huiyuen Tech Corporation Information
11.19.2 Huiyuen Tech Business Overview
11.19.3 Huiyuen Tech Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.19.4 Huiyuen Tech Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Huiyuen Tech Recent Developments
11.20 Owlstone Medical
11.20.1 Owlstone Medical Corporation Information
11.20.2 Owlstone Medical Business Overview
11.20.3 Owlstone Medical Breath Molecular Diagnostic Device Product Models, Descriptions and Specifications
11.20.4 Owlstone Medical Breath Molecular Diagnostic Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Owlstone Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Breath Molecular Diagnostic Device Industry Chain
12.2 Breath Molecular Diagnostic Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Breath Molecular Diagnostic Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Breath Molecular Diagnostic Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Breath Molecular Diagnostic Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Breath Molecular Diagnostic Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Breath Molecular Diagnostic Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Breath Molecular Diagnostic Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Breath Molecular Diagnostic Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Breath Molecular Diagnostic Device Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Breath Molecular Diagnostic Device Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Breath Molecular Diagnostic Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Breath Molecular Diagnostic Device Sales by Region (2020-2025) & (Units)
 Table 8. Global Breath Molecular Diagnostic Device Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Breath Molecular Diagnostic Device Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Breath Molecular Diagnostic Device Sales Share by Manufacturers (2020-2025)
 Table 12. Global Breath Molecular Diagnostic Device Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Breath Molecular Diagnostic Device Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Breath Molecular Diagnostic Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breath Molecular Diagnostic Device as of 2024)
 Table 16. Global Breath Molecular Diagnostic Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Breath Molecular Diagnostic Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Breath Molecular Diagnostic Device Manufacturing Base and Headquarters
 Table 19. Global Breath Molecular Diagnostic Device Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Breath Molecular Diagnostic Device Sales by Type (2020-2025) & (Units)
 Table 23. Global Breath Molecular Diagnostic Device Sales by Type (2026-2031) & (Units)
 Table 24. Global Breath Molecular Diagnostic Device Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Breath Molecular Diagnostic Device Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Breath Molecular Diagnostic Device ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Breath Molecular Diagnostic Device Sales by Application (2020-2025) & (Units)
 Table 29. Global Breath Molecular Diagnostic Device Sales by Application (2026-2031) & (Units)
 Table 30. Breath Molecular Diagnostic Device High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Breath Molecular Diagnostic Device Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Breath Molecular Diagnostic Device Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Breath Molecular Diagnostic Device ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Breath Molecular Diagnostic Device Growth Accelerators and Market Barriers
 Table 37. North America Breath Molecular Diagnostic Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Breath Molecular Diagnostic Device Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Breath Molecular Diagnostic Device Growth Accelerators and Market Barriers
 Table 40. Europe Breath Molecular Diagnostic Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Breath Molecular Diagnostic Device Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Breath Molecular Diagnostic Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Breath Molecular Diagnostic Device Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Breath Molecular Diagnostic Device Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Breath Molecular Diagnostic Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Breath Molecular Diagnostic Device Investment Opportunities and Key Challenges
 Table 47. Central and South America Breath Molecular Diagnostic Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Breath Molecular Diagnostic Device Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Breath Molecular Diagnostic Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. NIOX Group plc Corporation Information
 Table 51. NIOX Group plc Description and Major Businesses
 Table 52. NIOX Group plc Product Models, Descriptions and Specifications
 Table 53. NIOX Group plc Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. NIOX Group plc Sales Value Proportion by Product in 2024
 Table 55. NIOX Group plc Sales Value Proportion by Application in 2024
 Table 56. NIOX Group plc Sales Value Proportion by Geographic Area in 2024
 Table 57. NIOX Group plc Breath Molecular Diagnostic Device SWOT Analysis
 Table 58. NIOX Group plc Recent Developments
 Table 59. Headway Corporation Information
 Table 60. Headway Description and Major Businesses
 Table 61. Headway Product Models, Descriptions and Specifications
 Table 62. Headway Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Headway Sales Value Proportion by Product in 2024
 Table 64. Headway Sales Value Proportion by Application in 2024
 Table 65. Headway Sales Value Proportion by Geographic Area in 2024
 Table 66. Headway Breath Molecular Diagnostic Device SWOT Analysis
 Table 67. Headway Recent Developments
 Table 68. Sunvou Medical Electronics Co Corporation Information
 Table 69. Sunvou Medical Electronics Co Description and Major Businesses
 Table 70. Sunvou Medical Electronics Co Product Models, Descriptions and Specifications
 Table 71. Sunvou Medical Electronics Co Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Sunvou Medical Electronics Co Sales Value Proportion by Product in 2024
 Table 73. Sunvou Medical Electronics Co Sales Value Proportion by Application in 2024
 Table 74. Sunvou Medical Electronics Co Sales Value Proportion by Geographic Area in 2024
 Table 75. Sunvou Medical Electronics Co Breath Molecular Diagnostic Device SWOT Analysis
 Table 76. Sunvou Medical Electronics Co Recent Developments
 Table 77. CAIRE (NGK) Corporation Information
 Table 78. CAIRE (NGK) Description and Major Businesses
 Table 79. CAIRE (NGK) Product Models, Descriptions and Specifications
 Table 80. CAIRE (NGK) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. CAIRE (NGK) Sales Value Proportion by Product in 2024
 Table 82. CAIRE (NGK) Sales Value Proportion by Application in 2024
 Table 83. CAIRE (NGK) Sales Value Proportion by Geographic Area in 2024
 Table 84. CAIRE (NGK) Breath Molecular Diagnostic Device SWOT Analysis
 Table 85. CAIRE (NGK) Recent Developments
 Table 86. Richen Holding Corporation Information
 Table 87. Richen Holding Description and Major Businesses
 Table 88. Richen Holding Product Models, Descriptions and Specifications
 Table 89. Richen Holding Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Richen Holding Sales Value Proportion by Product in 2024
 Table 91. Richen Holding Sales Value Proportion by Application in 2024
 Table 92. Richen Holding Sales Value Proportion by Geographic Area in 2024
 Table 93. Richen Holding Breath Molecular Diagnostic Device SWOT Analysis
 Table 94. Richen Holding Recent Developments
 Table 95. Meridian Bioscience Corporation Information
 Table 96. Meridian Bioscience Description and Major Businesses
 Table 97. Meridian Bioscience Product Models, Descriptions and Specifications
 Table 98. Meridian Bioscience Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Meridian Bioscience Recent Developments
 Table 100. CAPNIA, Inc. Corporation Information
 Table 101. CAPNIA, Inc. Description and Major Businesses
 Table 102. CAPNIA, Inc. Product Models, Descriptions and Specifications
 Table 103. CAPNIA, Inc. Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. CAPNIA, Inc. Recent Developments
 Table 105. Kibion​​ Corporation Information
 Table 106. Kibion​​ Description and Major Businesses
 Table 107. Kibion​​ Product Models, Descriptions and Specifications
 Table 108. Kibion​​ Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Kibion​​ Recent Developments
 Table 110. Otsuka Electronics Corporation Information
 Table 111. Otsuka Electronics Description and Major Businesses
 Table 112. Otsuka Electronics Product Models, Descriptions and Specifications
 Table 113. Otsuka Electronics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Otsuka Electronics Recent Developments
 Table 115. LEYI BIOLOGY Corporation Information
 Table 116. LEYI BIOLOGY Description and Major Businesses
 Table 117. LEYI BIOLOGY Product Models, Descriptions and Specifications
 Table 118. LEYI BIOLOGY Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. LEYI BIOLOGY Recent Developments
 Table 120. Eco Physics AG Corporation Information
 Table 121. Eco Physics AG Description and Major Businesses
 Table 122. Eco Physics AG Product Models, Descriptions and Specifications
 Table 123. Eco Physics AG Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Eco Physics AG Recent Developments
 Table 125. Shenzhen Breax Corporation Information
 Table 126. Shenzhen Breax Description and Major Businesses
 Table 127. Shenzhen Breax Product Models, Descriptions and Specifications
 Table 128. Shenzhen Breax Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Shenzhen Breax Recent Developments
 Table 130. QUINTRON Corporation Information
 Table 131. QUINTRON Description and Major Businesses
 Table 132. QUINTRON Product Models, Descriptions and Specifications
 Table 133. QUINTRON Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. QUINTRON Recent Developments
 Table 135. Beijing Wanliandaxinke Instruments Co Corporation Information
 Table 136. Beijing Wanliandaxinke Instruments Co Description and Major Businesses
 Table 137. Beijing Wanliandaxinke Instruments Co Product Models, Descriptions and Specifications
 Table 138. Beijing Wanliandaxinke Instruments Co Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Beijing Wanliandaxinke Instruments Co Recent Developments
 Table 140. SIMES SIKMA Corporation Information
 Table 141. SIMES SIKMA Description and Major Businesses
 Table 142. SIMES SIKMA Product Models, Descriptions and Specifications
 Table 143. SIMES SIKMA Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. SIMES SIKMA Recent Developments
 Table 145. Beijing Safe Heart Technology Corporation Information
 Table 146. Beijing Safe Heart Technology Description and Major Businesses
 Table 147. Beijing Safe Heart Technology Product Models, Descriptions and Specifications
 Table 148. Beijing Safe Heart Technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. Beijing Safe Heart Technology Recent Developments
 Table 150. e-LinkCare Meditech Co Corporation Information
 Table 151. e-LinkCare Meditech Co Description and Major Businesses
 Table 152. e-LinkCare Meditech Co Product Models, Descriptions and Specifications
 Table 153. e-LinkCare Meditech Co Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. e-LinkCare Meditech Co Recent Developments
 Table 155. ChromX Health Corporation Information
 Table 156. ChromX Health Description and Major Businesses
 Table 157. ChromX Health Product Models, Descriptions and Specifications
 Table 158. ChromX Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 159. ChromX Health Recent Developments
 Table 160. Huiyuen Tech Corporation Information
 Table 161. Huiyuen Tech Description and Major Businesses
 Table 162. Huiyuen Tech Product Models, Descriptions and Specifications
 Table 163. Huiyuen Tech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 164. Huiyuen Tech Recent Developments
 Table 165. Owlstone Medical Corporation Information
 Table 166. Owlstone Medical Description and Major Businesses
 Table 167. Owlstone Medical Product Models, Descriptions and Specifications
 Table 168. Owlstone Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 169. Owlstone Medical Recent Developments
 Table 170. Key Raw Materials Distribution
 Table 171. Raw Materials Key Suppliers
 Table 172. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 173. Milestones in Production Technology Evolution
 Table 174. Distributors List
 Table 175. Market Trends and Market Evolution
 Table 176. Market Drivers and Opportunities
 Table 177. Market Challenges, Risks, and Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources


List of Figures
 Figure 1. Breath Molecular Diagnostic Device Product Picture
 Figure 2. Global Breath Molecular Diagnostic Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. C13 Type Product Picture
 Figure 4. NO Type Product Picture
 Figure 5. H2/CO Type Product Picture
 Figure 6. VOCs Type Product Picture
 Figure 7. Global Breath Molecular Diagnostic Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Physical Examination Center
 Figure 11. Other
 Figure 12. Breath Molecular Diagnostic Device Report Years Considered
 Figure 13. Global Breath Molecular Diagnostic Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Breath Molecular Diagnostic Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Breath Molecular Diagnostic Device Revenue Market Share by Region (2020-2031)
 Figure 17. Global Breath Molecular Diagnostic Device Sales (2020-2031) & (Units)
 Figure 18. Global Breath Molecular Diagnostic Device Sales (CAGR) by Region (2020-2031) (Units)
 Figure 19. Global Breath Molecular Diagnostic Device Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Breath Molecular Diagnostic Device Sales Volume Market Share in 2024
 Figure 21. Global Breath Molecular Diagnostic Device Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. C13 Type Revenue Market Share by Manufacturer in 2024
 Figure 24. NO Type Revenue Market Share by Manufacturer in 2024
 Figure 25. H2/CO Type Revenue Market Share by Manufacturer in 2024
 Figure 26. VOCs Type Revenue Market Share by Manufacturer in 2024
 Figure 27. Global Breath Molecular Diagnostic Device Sales Market Share by Type (2020-2031)
 Figure 28. Global Breath Molecular Diagnostic Device Revenue Market Share by Type (2020-2031)
 Figure 29. Global Breath Molecular Diagnostic Device Sales Market Share by Application (2020-2031)
 Figure 30. Global Breath Molecular Diagnostic Device Revenue Market Share by Application (2020-2031)
 Figure 31. North America Breath Molecular Diagnostic Device Sales YoY (2020-2031) & (Units)
 Figure 32. North America Breath Molecular Diagnostic Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. North America Top 5 Manufacturers Breath Molecular Diagnostic Device Sales Revenue (US$ Million) in 2024
 Figure 34. North America Breath Molecular Diagnostic Device Sales Volume (Units) by Type (2020- 2031)
 Figure 35. North America Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 36. North America Breath Molecular Diagnostic Device Sales Volume (Units) by Application (2020-2031)
 Figure 37. North America Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 38. US Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 39. Canada Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 40. Mexico Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 41. Europe Breath Molecular Diagnostic Device Sales YoY (2020-2031) & (Units)
 Figure 42. Europe Breath Molecular Diagnostic Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Europe Top 5 Manufacturers Breath Molecular Diagnostic Device Sales Revenue (US$ Million) in 2024
 Figure 44. Europe Breath Molecular Diagnostic Device Sales Volume (Units) by Type (2020-2031)
 Figure 45. Europe Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Europe Breath Molecular Diagnostic Device Sales Volume (Units) by Application (2020-2031)
 Figure 47. Europe Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Germany Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 49. France Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 50. U.K. Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 51. Italy Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 52. Russia Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Breath Molecular Diagnostic Device Sales YoY (2020-2031) & (Units)
 Figure 54. Asia-Pacific Breath Molecular Diagnostic Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Asia-Pacific Top 8 Manufacturers Breath Molecular Diagnostic Device Sales Revenue (US$ Million) in 2024
 Figure 56. Asia-Pacific Breath Molecular Diagnostic Device Sales Volume (Units) by Type (2020- 2031)
 Figure 57. Asia-Pacific Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 58. Asia-Pacific Breath Molecular Diagnostic Device Sales Volume (Units) by Application (2020-2031)
 Figure 59. Asia-Pacific Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Indonesia Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 61. Japan Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 62. South Korea Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 63. China Taiwan Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 64. India Breath Molecular Diagnostic Device Revenue (2020-2031) & (US$ Million)
 Figure 65. Central and South America Breath Molecular Diagnostic Device Sales YoY (2020-2031) & (Units)
 Figure 66. Central and South America Breath Molecular Diagnostic Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 67. Central and South America Top 5 Manufacturers Breath Molecular Diagnostic Device Sales Revenue (US$ Million) in 2024
 Figure 68. Central and South America Breath Molecular Diagnostic Device Sales Volume (Units) by Type (2021-2031)
 Figure 69. Central and South America Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 70. Central and South America Breath Molecular Diagnostic Device Sales Volume (Units) by Application (2020-2031)
 Figure 71. Central and South America Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 72. Brazil Breath Molecular Diagnostic Device Revenue (2020-2025) & (US$ Million)
 Figure 73. Argentina Breath Molecular Diagnostic Device Revenue (2020-2025) & (US$ Million)
 Figure 74. Middle East, and Africa Breath Molecular Diagnostic Device Sales YoY (2020-2031) & (Units)
 Figure 75. Middle East and Africa Breath Molecular Diagnostic Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Middle East and Africa Top 5 Manufacturers Breath Molecular Diagnostic Device Sales Revenue (US$ Million) in 2024
 Figure 77. Middle East and Africa Breath Molecular Diagnostic Device Sales Volume (Units) by Type (2021-2031)
 Figure 78. South America Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Middle East and Africa Breath Molecular Diagnostic Device Sales Volume (Units) by Application (2020-2031)
 Figure 80. Middle East and Africa Breath Molecular Diagnostic Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. GCC Countries Breath Molecular Diagnostic Device Revenue (2020-2025) & (US$ Million)
 Figure 82. Turkey Breath Molecular Diagnostic Device Revenue (2020-2025) & (US$ Million)
 Figure 83. Egypt Breath Molecular Diagnostic Device Revenue (2020-2025) & (US$ Million)
 Figure 84. South Africa Breath Molecular Diagnostic Device Revenue (2020-2025) & (US$ Million)
 Figure 85. Breath Molecular Diagnostic Device Industry Chain Mapping
 Figure 86. Regional Breath Molecular Diagnostic Device Manufacturing Base Distribution (%)
 Figure 87. Global Breath Molecular Diagnostic Device Production Market Share by Region (2020-2031)
 Figure 88. Breath Molecular Diagnostic Device Production Process
 Figure 89. Regional Breath Molecular Diagnostic Device Production Cost Structure
 Figure 90. Channels of Distribution (Direct Vs Distribution)
 Figure 91. Bottom-up and Top-down Approaches for This Report
 Figure 92. Data Triangulation
 Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart